Published in Arq Bras Cir Dig on July 09, 2014
INFLUENCE OF HEPATOCELLULAR CARCINOMA ETIOLOGY IN THE SURVIVAL AFTER RESECTION. Arq Bras Cir Dig (2016) 0.80
Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective. Insights Imaging (2015) 0.78
TRANEXAMIC ACID ACTION ON LIVER REGENERATION AFTER PARTIAL HEPATECTOMY: EXPERIMENTAL MODEL IN RATS. Arq Bras Cir Dig (2016) 0.77
Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg (2012) 2.49
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg (2010) 1.85
Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. Br J Surg (2013) 1.62
Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases. Surgery (2010) 1.56
Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg (2007) 1.46
The developing clinical problem of chemotherapy-induced hepatic injury. ANZ J Surg (2011) 1.43
Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol (2009) 1.28
The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol (2009) 1.21
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15
Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol (2009) 1.12
Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol (2009) 1.11
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery (2009) 1.10
The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery (2012) 1.06
Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades. Ann Surg Oncol (2012) 1.04
The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc (1991) 1.01
Recent advances in the curative treatment of colorectal liver metastases. Gastrointest Cancer Res (2011) 1.00
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. J Am Coll Surg (2012) 0.96
Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol (2011) 0.94
Chemotherapy-associated hepatotoxicity: do we need to be concerned? Ann Surg Oncol (2009) 0.92
Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg (2010) 0.89
Resection of colorectal liver metastases in the elderly: does age matter? Colorectal Dis (2012) 0.84
Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg (2012) 0.83
Efficacy of follow-up after surgical treatment of colorectal liver metastases. Eur J Surg Oncol (2008) 0.81
Chemotherapy liver injury. Surgery (2010) 0.77
Colorectal Cancer OncoGuia. Clin Transl Oncol (2010) 0.77